Kevin K Zarrabi
Overview
Explore the profile of Kevin K Zarrabi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zarrabi K, Narayan V, Mille P, Zibelman M, Miron B, Bashir B, et al.
Ther Adv Urol
. 2023 Jun;
15:17562872231182219.
PMID: 37359737
Prostate cancer is the most common cancer among men and the second leading cause of cancer-related deaths in men in the United States. The treatment paradigm for prostate cancer has...
12.
Simao D, Zarrabi K, Mendes J, Luz R, Garcia J, Kelly W, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900202
Over the past decade, immunotherapy has demonstrated an impressive improvement in treatment outcomes for multiple cancers. Following the landmark approvals for use of immune checkpoint inhibitors, new challenges emerged in...
13.
Zarrabi K, Lanade O, Geynisman D
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230530
The therapeutic landscape for metastatic renal cell carcinoma has rapidly evolved over the years, and we are now in an era of combination therapy strategies employing immune checkpoint blockade and...
14.
Zarrabi K, Handorf E, Miron B, Zibelman M, Anari F, Ghatalia P, et al.
Oncologist
. 2022 Oct;
28(2):157-164.
PMID: 36200791
Background: Treatment of metastatic renal cell carcinoma (mRCC) is rapidly evolving with new combination therapies demonstrating improved response rates and survival. There are no head-to-head prospective trials comparing an immunotherapy...
15.
Zarrabi K, Galloway T, Flieder D, Kumar S, Judd J, Bauman J
Head Neck
. 2022 May;
44(8):E25-E30.
PMID: 35546490
Background: Human papillomavirus (HPV)-mediated oropharyngeal squamous cell carcinoma is a subset of head and neck cancer with a unique mechanism of carcinogenesis. Local disease is treated definitively with a multimodal...